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In response to the
epidemic of obesity,
the lack of effective
medical therapy,
and the costs of
complications, gov-
ernments are in-
creasingly seeking
legislative ap-
proaches to prevent
or reverse the con-
dition.While browsing through potential reading material recently, my attentionwas unexpectedly drawn to a “Special Report on Obesity” in the journalThe Economist (1). As physicians, and particularly cardiovascular specialists,
we are well aware of the enormous health care burden currently imposed by overweight
and obesity. However, in reading the article I was impressed with the many economic
and societal aspects of the condition, especially in regards to potential remedies. In fact,
in many respects government and industry may have been more active in pursuing solu-
tions than have we in medicine. Therefore, I thought that I might share some of the
thoughts that were provoked in reading the article.
Although I have heard or read the statistics regarding overweight/obesity many times,
they still serve to startle me. Data indicate that two-thirds of people in the United
States are overweight (body mass index [BMI] 25 kg/m2), while 36% of adults and
17% of children are obese (BMI 30 kg/m2). Excessive fatness is also rapidly becoming
prevalent worldwide. At least 24% of adults in Great Britain are obese, as are more than
20% of adults in countries such as Brazil, South Africa, and the United Arab Emirates.
Obesity is even increasing in developing countries, such as China and India, and it is
estimated that roughly one-third of the population of the world is overweight. It is likely
that this has been a major contributor to the transition from infection to chronic dis-
eases as the predominant cause of death in the developing world. Approximately 44% of
diabetes and 23% of ischemic heart disease cases have been attributed to corpulence by
the World Health Organization, and several years ago obesity-related illness was esti-
mated to be responsible for up to 20% of total health-care costs.
In large measure the increasing prevalence of overweight/obesity has been related to
changing culture, lifestyles, and economics. Increasing wealth has increased the availabil-
ity of (often highly-refined) foodstuffs, and decreased the need for physical exertion. Soft
drinks and fast food that are frequently highly caloric have become more accessible and
affordable. It is not surprising, therefore, that enlarging body mass has increased more
rapidly as a cause of disease since in the last 2 decades than any other disease cause.
The cause of obesity seems deceptively obvious; it occurs if you eat more calories than
you burn. In fact, the size of the portion served and the speed with which it is con-
sumed have been shown to influence weight. However, it is well documented that obe-
sity is less prevalent among highly educated and wealthy individuals than those with
lower income and less education, although the reasons are not precisely defined. Physiol-
ogy also plays an important role in the process. The interaction of hormones, such as
ghrelin and leptin impact appetite, as does the central nervous system. To some extent,
these mechanisms seem to be influenced by genetic factors, although the strength of the
role of genes is uncertain. These physiologic mechanisms appear to have been designed
to protect our primitive ancestors for whom long intervals without food made it impor-
tant to store extra calories when they were available. Unfortunately, in our current socio-
economic environment these mechanisms can have significant adverse effects.
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is also not simple. Of course there is the clear association
of obesity with hypertension, hyperglycemia, and hyper-
lipidemia, all of which predispose to a variety of disorders.
In addition, obesity is often accompanied by insulin resis-
tance and diabetes, with the associated complications of
these conditions. However, complications seem to be
more closely related to abdominal adiposity and an in-
creased waist-to-hip measurement. It has also now been
well documented that there is a subset of fat individuals
who are metabolically normal (healthy or fit fat), typically
exercise regularly and are well conditioned, and do not
seem to experience an increased morbidity or mortality.
These individuals often exhibit an increased lean body
mass. Moreover, a number of studies have established the
relationship between visceral adipose tissue, inflammation,
and subsequent adverse conditions. Thus, the BMI does
not tell the whole story when it comes to predicting the
effects of overweight/obesity.
Given the increasing prevalence and detrimental effects
of obesity, it is stunning that few medical interventions
are available. Agents that have proven to be of some ben-
efit have also been shown to have severe side effects. Sev-
eral newer drugs have been approved, but remain to be
evaluated in general practice. Perhaps the most effective
intervention at present is bariatric surgery, which has
shown the ability to produce weight loss and reduce sec-
ondary abnormalities. It is perhaps a strong statement
concerning the current state of overweight that a surgical
procedure is increasingly being performed as the best
therapy for morbid obesity. While it is easy to say that
the obvious answer to fatness is to eat less and exercise
more, and that weight is subject to choices made by a
patient, many of the physiological mechanisms discussed
earlier can conspire to make weight loss more difficult
than weight gain.
In response to the epidemic of obesity, the lack of ef-
fective medical therapy, and the costs of complications,
governments are increasingly seeking legislative ap-
proaches to prevent or reverse the condition. Much atten-
tion focuses, of course, upon the food industry. Fast food,
including soft drinks, has been felt to be responsible for
much of the fat gain in the United States, and the com-
panies involved are rapidly expanding in the rest of the
world. Obviously, a reduction in the size and/or caloric
content of their products could be of benefit in reducing
obesity. The perception of the major role of the food
merchants in the current epidemic has been such that the
industry is attempting to be proactive in providing health-
ier food choices. In the United States, 16 companies have
promised to cut 1.5 trillion calories from their products,and 21 English companies have entered a “Responsibility
Deal” with the Department of Health to help people re-
duce their caloric intake. However, as public companies,
these entities have a responsibility to stockholders to
achieve profits. In the past, stockholders have rallied
against abandoning very profitable foods that are tasty but
not necessarily nutritious. An additional consideration is
that it is not always clear what constitutes healthy food,
nor is such fare always well received by customers. The
classic example is the reduced fat McLean Deluxe ham-
burger marketed by McDonald’s several years ago that
was a failure in the marketplace. Industry is responsible
for making nutritious food that is appealing, but the pub-
lic must be accepting of such offerings even if they are
less tasty.
Governments have several options for addressing the
obesity epidemic: they can conduct public health cam-
paigns, use the mechanism of taxes, or eliminate the sale
of products. Legislative action can be directed to the food
suppliers or to the public. Considerable public health
campaigns are ongoing as exemplified by the increasing
requirements to provide information about the caloric
content of products. Thus far, the response of industry to
potential regulatory action has primarily been to increase
education and emphasize the role of personal responsibil-
ity. The potential exists for the government to increase
taxes on food that is deemed to be unhealthy. This was
done in New York City for cigarettes with excellent suc-
cess. However, data indicates that the tax must be a mini-
mum of 20% to be effective, an amount that would be
politically unpopular. Perhaps the boldest governmental
intervention has been in New York City where Mayor
Bloomberg has obtained the Health Department agree-
ment to ban giant size portions of soft drinks with high
sugar content. Not surprisingly, this action has been very
controversial, with opponents maintaining that this is the
introduction of the “nanny state” where the freedom to
make lifestyle choices is taken from the individual by the
government. Opponents argue that if the government can
decide what kind of soft drink you can have in the name
of good health, what else can it decide, and where does
the authority stop. Clearly it is in the purview of the gov-
ernment to strive to eliminate products or conditions that
compromise good health. The way in which the govern-
ment pursues this activity will likely depend upon the
growth of the obesity epidemic and its cost to society.
It is of some interest to me that the medical profession
has been a bit less active in regard to control of obesity
than I might have expected. Although I may be unaware
of specific activities, I have not seen the same kind of
organized effort for corpulence that was apparent for
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gard to the deleterious effects of obesity and the need to
lose weight, perhaps we could achieve more if we orga-
nized with a common voice to express our concerns about
the danger of having excess weight.
There is little question that overweight/obesity repre-
sents an enormous and increasing problem for our health
care system, particularly in regard to cardiovascular disor-
ders. The remedy for this problem is likely multifactorial.
Education, encouragement, and assistance in losing
weight certainly should be the cornerstone of our action
with patients. Perhaps as a profession we can take a more
public role about the need for a concerted effort against
the epidemic. Given the difficulties in losing weight,
strong efforts must be directed to preventing obesity to
begin with. Industry must be incentivized to make ap-
pealing, nutritional foods, and the public must be con-
vinced that foregoing an acquired taste for better health is
important. It appears clear that financial incentives would
be most effective in changing the eating habits, but these
would be very difficult to implement in the form of taxes.
Perhaps smaller, more individual incentives could be im-
plemented by insurers or employers to achieve a reduction
in weight. The process of banning products seems to be abit of a slippery slope in regard to food; how do you de-
termine which products to ban? Nevertheless, the chal-
lenges presented by obesity to health care costs and the
requirement to provide adequate foodstuffs to a more
populous and overweight world could provoke society to
take more drastic measures. Interestingly, although the
consequences of overweight/obesity are primarily medical,
economic and regulatory agencies appear to be playing the
major role in seeking a solution. Surely the time has come
for the medical community to become more organized
and proactive in engaging the public and the food indus-
try to emphasize the health hazards associated with obe-
sity and seek solutions to the problem.
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